Drug Promotion, Quality and Patient Safety

Presented opening remarks at the symposium on “Drug Promotion, Quality and Patient Safety”. The aim of the symposium was to provide researchers and policy-makers an opportunity to explore drug promotion regulation in terms of quality of information and impacts on patient safety. It also included discussion of the results of a comparative study examining the quality of information provided to primary care physicians by pharmaceutical sales representatives in the United States, France and Canada. November 29, 2010, Toronto, Ontario

You may also like...

Leave a Reply